Ambassador Intra board to meet on May 28 to consider Q4FY26 results
Ambassador Intra Holdings Limited's board is set to meet on May 28, 2026, to approve the standalone audited financial results for the quarter and fiscal year ended March 31, 2026. The trading window for insiders has been closed since April 1, 2026, in accordance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Ambassador Intra Holdings Limited has announced that its board of directors will meet on Thursday, May 28, 2026. The primary agenda for the meeting is to consider and approve the standalone audited financial results of the company for the quarter and year ended March 31, 2026, along with the audit report issued by the statutory auditor.
The meeting is scheduled to take place at the company's registered office located at 401, Aishvarya 02, Prakashnagar C.H.S.L, Uttamnagar, Maninagar, Ahmedabad. The board will also consider any other business that may be placed before it with the permission of the Chairman.
Trading Window Closure
In compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the company has informed its designated persons, including directors, about the closure of the trading window. The window closed on April 1, 2026, and will remain closed until 48 hours after the declaration of the audited standalone financial results for the period ending March 31, 2026.
Key Meeting Details
| Detail | Information |
|---|---|
| Company Name | Ambassador Intra Holdings Limited |
| Meeting Date | May 28, 2026 |
| Meeting Purpose | Consideration of Q4 and FY26 Standalone Audited Financial Results |
| Venue | Registered Office, Ahmedabad |
| Trading Window Closure | April 1, 2026 to 48 hours post-result declaration |
How might Ambassador Intra Holdings' FY26 financial performance compare to industry peers in the holdings sector, and what growth trajectory could investors expect for FY27?
Following the trading window reopening post-results, what potential stock price movements or institutional investor activity could emerge based on the company's financial health?
Will the board consider declaring dividends or announcing any capital allocation strategy alongside the FY26 results that could signal future shareholder value creation?


























